XML 22 R10.htm IDEA: XBRL DOCUMENT v3.26.1
Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities
4. Cash Equivalents and Marketable Securities
The following tables summarize the amortized cost and fair value of the Company’s cash equivalents and marketable securities by major category for the periods presented (in thousands):
June 30, 2026
Amortized CostGross Unrealized GainGross Unrealized LossEstimated Fair Value
Cash equivalents:
Money market funds$32,527 $— $— $32,527 
U.S. Treasury securities9,978 — — 9,978 
Total cash equivalents$42,505 $— $— $42,505 
Marketable securities:
U.S. Treasury securities$104,424 $— $(118)$104,306 
Total marketable securities$104,424 $— $(118)$104,306 
December 31, 2025
Amortized CostGross Unrealized GainGross Unrealized LossEstimated Fair Value
Cash equivalents:
Money market funds$33,320 $— $— $33,320 
Total cash equivalents$33,320 $— $— $33,320 
Marketable securities:
U.S. Treasury securities$69,886 $22 $— $69,908 
Total marketable securities$69,886 $22 $— $69,908 
For the three and six months ended June 30, 2026, interest income was $1.2 million and $2.1 million, respectively, and was included within interest income and other, net in the condensed consolidated statements of operations and comprehensive (loss) income. Interest income for the three and six months ended June 30, 2025 was not material.